ArticleInternational journal of clinical and experimental pathology2015

SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors.

Zhongwu Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.